Loading...
BioMarin Pharmaceutical Inc.
BMRN•NASDAQ
Healthcare
Biotechnology
$62.92
$-1.16(-1.81%)
U.S. Market opens in 12h 2mBioMarin Pharmaceutical Inc. (BMRN) AI-Powered Stock Analysis
See how BioMarin Pharmaceutical Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBioMarin Pharmaceutical Inc. (BMRN) Stock Overall Grade
BioMarin Pharmaceutical Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to BioMarin Pharmaceutical Inc.'s overall stock rating.
Forecast
B+Score
74/100Financial Growth
CScore
40/100Fundamental Growth
BScore
68/100Key Ratios
B+Score
71/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
BScore
67/100BioMarin Pharmaceutical Inc. (BMRN) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 74/100 (B+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (68/100, B) highlight its stability, while Key Ratios (71/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (67/100,B) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each BioMarin Pharmaceutical Inc. stock grade, including financials, comparisons, and forecasts.